Caption Management, LLC Bluebird Bio, Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $139,500 - $251,500	50,000 New	50,000 $164,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $1.35 Million - $2.52 Million	-120,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $3.11 Million - $3.81 Million	-172,500 Reduced 58.97%	120,000 $3.84 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $4.4 Million - $9 Million	265,500 Added 983.33%	292,500 $8.82 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $235,440 - $571,500	-9,000 Reduced 25.0%	27,000 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $1.4 Million - $2.19 Million	23,500 Added 188.0%	36,000 $3.31 Million
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $948,000 - $1.32 Million	-12,500 Reduced 50.0%	12,500 $1.59 Million
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $1.61 Million - $2.6 Million	25,000 New	25,000 $3.93 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $628M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.